These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
315 related articles for article (PubMed ID: 2646536)
1. A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure. DiBianco R; Shabetai R; Kostuk W; Moran J; Schlant RC; Wright R N Engl J Med; 1989 Mar; 320(11):677-83. PubMed ID: 2646536 [TBL] [Abstract][Full Text] [Related]
2. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. Packer M; Carver JR; Rodeheffer RJ; Ivanhoe RJ; DiBianco R; Zeldis SM; Hendrix GH; Bommer WJ; Elkayam U; Kukin ML N Engl J Med; 1991 Nov; 325(21):1468-75. PubMed ID: 1944425 [TBL] [Abstract][Full Text] [Related]
3. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE Study. Packer M; Gheorghiade M; Young JB; Costantini PJ; Adams KF; Cody RJ; Smith LK; Van Voorhees L; Gourley LA; Jolly MK N Engl J Med; 1993 Jul; 329(1):1-7. PubMed ID: 8505940 [TBL] [Abstract][Full Text] [Related]
4. A Canadian multicentre study of a 48 h infusion of milrinone in patients with severe heart failure. Pflugfelder PW; O'Neill BJ; Ogilvie RI; Beanlands DS; Tanser PH; Tihal H; Mizgala HF; Fitchett DH; Kostuk WJ Can J Cardiol; 1991; 7(1):5-10. PubMed ID: 2025794 [TBL] [Abstract][Full Text] [Related]
5. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study. Cohn JN; Archibald DG; Ziesche S; Franciosa JA; Harston WE; Tristani FE; Dunkman WB; Jacobs W; Francis GS; Flohr KH N Engl J Med; 1986 Jun; 314(24):1547-52. PubMed ID: 3520315 [TBL] [Abstract][Full Text] [Related]
6. Sex-based differences in the effect of digoxin for the treatment of heart failure. Rathore SS; Wang Y; Krumholz HM N Engl J Med; 2002 Oct; 347(18):1403-11. PubMed ID: 12409542 [TBL] [Abstract][Full Text] [Related]
7. Short-term intravenous milrinone for severe congestive heart failure: the good, bad, and not so good. Varriale P; Ramaprasad S Pharmacotherapy; 1997; 17(2):371-4. PubMed ID: 9085331 [TBL] [Abstract][Full Text] [Related]
8. The effect of digoxin on mortality and morbidity in patients with heart failure. Digitalis Investigation Group N Engl J Med; 1997 Feb; 336(8):525-33. PubMed ID: 9036306 [TBL] [Abstract][Full Text] [Related]
9. Ibopamine vs. digoxin in chronic heart failure: a double-blind, crossover study. Alicandri C; Fariello R; Boni E; Zaninelli A; Muiesan G J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S77-82. PubMed ID: 2483444 [TBL] [Abstract][Full Text] [Related]
10. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. Singh SN; Fletcher RD; Fisher SG; Singh BN; Lewis HD; Deedwania PC; Massie BM; Colling C; Lazzeri D N Engl J Med; 1995 Jul; 333(2):77-82. PubMed ID: 7539890 [TBL] [Abstract][Full Text] [Related]
11. Effects of vesnarinone on morbidity and mortality in patients with heart failure. Vesnarinone Study Group. Feldman AM; Bristow MR; Parmley WW; Carson PE; Pepine CJ; Gilbert EM; Strobeck JE; Hendrix GH; Powers ER; Bain RP N Engl J Med; 1993 Jul; 329(3):149-55. PubMed ID: 8515787 [TBL] [Abstract][Full Text] [Related]
12. Heart failure in outpatients: a randomized trial of digoxin versus placebo. Lee DC; Johnson RA; Bingham JB; Leahy M; Dinsmore RE; Goroll AH; Newell JB; Strauss HW; Haber E N Engl J Med; 1982 Mar; 306(12):699-705. PubMed ID: 7038483 [TBL] [Abstract][Full Text] [Related]
13. Milrinone for long-term therapy of severe heart failure: clinical experience with special reference to maximal exercise tolerance. LeJemtel TH; Gumbardo D; Chadwick B; Rutman HI; Sonnenblick EH Circulation; 1986 Mar; 73(3 Pt 2):III213-8. PubMed ID: 3510777 [TBL] [Abstract][Full Text] [Related]
14. A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. Vesnarinone Trial Investigators. Cohn JN; Goldstein SO; Greenberg BH; Lorell BH; Bourge RC; Jaski BE; Gottlieb SO; McGrew F; DeMets DL; White BG N Engl J Med; 1998 Dec; 339(25):1810-6. PubMed ID: 9854116 [TBL] [Abstract][Full Text] [Related]
15. Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide. Kurien S; Warfield KT; Wood CM; Miller WL Am J Cardiol; 2006 Dec; 98(12):1627-30. PubMed ID: 17145223 [TBL] [Abstract][Full Text] [Related]
16. [Digoxin is effective in th treatment of patients with heart failure and sinus rhythm]. Lanas F; Standen D; Steinmann WC; Montecinos A; Stockins B Rev Med Chil; 1994 Oct; 122(10):1147-52. PubMed ID: 7659880 [TBL] [Abstract][Full Text] [Related]
17. Enalapril for severe congestive heart failure. A double-blind study. Jennings G; Kiat H; Nelson L; Kelly MJ; Kalff V; Johns J Med J Aust; 1984 Nov; 141(11):723-6. PubMed ID: 6094995 [TBL] [Abstract][Full Text] [Related]
18. Captopril versus digoxin in patients with coronary artery disease and mild heart failure. A prospective, double-blind, placebo-controlled multicenter study. The CADS Study Group. Just H; Drexler H; Taylor SH; Siegrist J; Schulgen G; Schumacher M Herz; 1993 Dec; 18 Suppl 1():436-43. PubMed ID: 8125424 [TBL] [Abstract][Full Text] [Related]
19. [Additive effects of milrinone and dobutamine in severe heart failure]. Meissner A; Herrmann G; Gerdesmeyer L; Simon R Z Kardiol; 1992 May; 81(5):266-71. PubMed ID: 1621407 [TBL] [Abstract][Full Text] [Related]
20. [Right ventricular function and effort tolerance in patients with chronic congestive heart insufficiency. A cross-over double-blind study]. Montes Orbe PM; Ormaetxe JM; Martínez JD; Rodríguez E; Ruiz de Azúa E; Iriarte MM Rev Esp Cardiol; 1990 Mar; 43(3):137-41. PubMed ID: 2185526 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]